The Ozempic Effect Of 2023

Ozempic’s near-to medium-term risks are overblown, notes CFRA Research’s Arun Sundaram. He discusses the Ozempic effect of 2023. He talks about how while longer-term risks could be more justified, food and beverage manufacturers have time to innovate. He suggests that by 2030, we see total food and beverage consumption down by a modest 1% to 2% due to the rise of AOMs, and categories that are at most risk are those that are high in fat, sugar, sodium, or carbs. He then goes over CFRA’s top packaged food picks for 2024. CFRA has a strong buy rating on Mondelez (MDLZ), Kraft Heinz (KHC), Coca-Cola (KO), and PepsiCo (PEP). Tune in to find out more about the stock market today.

Market On Close

02 Jan 2024

SHARE

ON AIR
4:00 pm
Trading 360
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
ON AIR
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
education
7:30 pm
Your First Trade
REPLAY
8:00 pm
Trading 360
REPLAY
9:00 pm
Market Overtime
REPLAY
education
9:30 pm
Your First Trade
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now